Tim Flaadt, Dr.
University Hospital Tuebingen, Department of Pediatrics and Adolescent Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tim Flaadt, Dr. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:10 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07108868 · A Phase I Dose Finding Study of MB-CART2219.1University Hospital Tuebingen · recruiting · Lymphoma, CLL, Acute Lymphoblastic Leukemia, Pediatric · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 12 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- TP12-1201 HPP AND PHEP COOPERATIVE AGREEMENTSU90TP000539 · COTPER · NORTH DAKOTA STATE DEPARTMENT OF HEALTH · fiscal years 2012 to 2015 · $1,174,159 awarded in 2015Same name and institution; not confirmed by an ID
- PUBLIC HEALTH PREPAREDNESS AND RESPONSE FOR BIOTERRORISMU90TP817000 · COTPER · NORTH DAKOTA STATE DEPARTMENT OF HEALTH · fiscal years 1999 to 2010 · $4,834,921 awarded in 2010Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.